The document discusses two types of acute respiratory distress syndrome (ARDS) - pulmonary (direct) ARDS and extrapulmonary (indirect) ARDS. It notes key differences in characteristics and responses to mechanical ventilation strategies between the two types. Specifically, extrapulmonary ARDS patients tend to have better responses to higher levels of positive end-expiratory pressure (PEEP) compared to pulmonary ARDS patients. The document also reviews various mechanical ventilation strategies and studies regarding lung-protective ventilation in ARDS.
An excellent tool to treat refractory hypoxia. Target audience are ICU junior physicians and Respiratory Therapists. It will take away the fear of "What is APRV?" from your hearts and you will feel ready to give it a try.
This slide presentation covers areas about physiology of respiratory system related to surgery and anaesthesia, definition of postoperative pulmonary complications (PPCs), risk of PPCs, screening for PPC risk and specific management for patients with increased risk.
An excellent tool to treat refractory hypoxia. Target audience are ICU junior physicians and Respiratory Therapists. It will take away the fear of "What is APRV?" from your hearts and you will feel ready to give it a try.
This slide presentation covers areas about physiology of respiratory system related to surgery and anaesthesia, definition of postoperative pulmonary complications (PPCs), risk of PPCs, screening for PPC risk and specific management for patients with increased risk.
Stress & Strain during Lung Protective Ventilation Egypt Pulmonary Critical...Dr.Mahmoud Abbas
Stress & Strain During Lung Protective Ventilation. Presentation of Dr Lluis Blanch at Pulmonary Critical Care Egypt 2014 , the leading educational event and exhibition for Critical Care Medicine in Egypt. www.pccmegypt.com
There might be no safe ventilation. Much too often, all there is for us to measure at the bedside are nothing but global indicators of stress/strain, more or less refined. Heterogeneity at the alveolar level-inhomogeneities or stress raisers - render global parameters less useful than previously predicted. In fact, Mead had already stated it through his work on stress distribution at the alveolar level.
ECMO (VA ECMO) might be regarded as one other way of decatecholaminization (M.Singer). Stop stressing the already stressed heart. Unfortunately, fem-fem VA ECMO still needs inotropic support to lessen the LV distension. Levosimendan and IABP combined could help decrease the catecholamine usage in this context.
ĐÁNH GIÁ THÔNG SỐ THÔNG KHÍ VÀ TEST PHỤC HỒI PHẾ QUẢN TRÊN BỆNH NHI HEN TẠI PHÒNG TƯ VẤN HEN KHOA NHI BỆNH VIỆN BẠCH MAI
Phí tải Tài liệu. 20.000 liên hệ quangthuboss@gmail.com
Presented by Dr Lluis Blanch at the Egyptian African Critical care Summit held at Cairo, Egypt.
The Egyptian African Critical care Summit is the leading Critical care and Emergency medicine medical conference in Egypt.
Augmentation by Echo. Deidre Murphy examines advanced aspects of bedside echocardiography, and the immense amount of information it provides in a critical care setting.
Presented by D.Niall Ferguson at 9th Pulmonary Medicine Update Course held at Cairo, Egypt.
This course is the leading Pulmonary Critical Care event in Egypt. The course is organized by Scribe (www.scribeofegypt.com)
Scleroderma Associated Lung Disease is presented by
Jane Dematte MD, MBA, Director, ILD program
Division of Pulmonary and Critical Care, Northwestern Feinberg School of Medicine
Endovascular and surgical treatment of pulmonary embolism 26.11.17Ivo Petrov
Interventional treatment (thrombus fragmentation and supraselective fibrinolysis) of high and intermediate risk patients with pulmonary embolism.
Protocols of intervention, results, clinical cases provided
Explore natural remedies for syphilis treatment in Singapore. Discover alternative therapies, herbal remedies, and lifestyle changes that may complement conventional treatments. Learn about holistic approaches to managing syphilis symptoms and supporting overall health.
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...i3 Health
i3 Health is pleased to make the speaker slides from this activity available for use as a non-accredited self-study or teaching resource.
This slide deck presented by Dr. Kami Maddocks, Professor-Clinical in the Division of Hematology and
Associate Division Director for Ambulatory Operations
The Ohio State University Comprehensive Cancer Center, will provide insight into new directions in targeted therapeutic approaches for older adults with mantle cell lymphoma.
STATEMENT OF NEED
Mantle cell lymphoma (MCL) is a rare, aggressive B-cell non-Hodgkin lymphoma (NHL) accounting for 5% to 7% of all lymphomas. Its prognosis ranges from indolent disease that does not require treatment for years to very aggressive disease, which is associated with poor survival (Silkenstedt et al, 2021). Typically, MCL is diagnosed at advanced stage and in older patients who cannot tolerate intensive therapy (NCCN, 2022). Although recent advances have slightly increased remission rates, recurrence and relapse remain very common, leading to a median overall survival between 3 and 6 years (LLS, 2021). Though there are several effective options, progress is still needed towards establishing an accepted frontline approach for MCL (Castellino et al, 2022). Treatment selection and management of MCL are complicated by the heterogeneity of prognosis, advanced age and comorbidities of patients, and lack of an established standard approach for treatment, making it vital that clinicians be familiar with the latest research and advances in this area. In this activity chaired by Michael Wang, MD, Professor in the Department of Lymphoma & Myeloma at MD Anderson Cancer Center, expert faculty will discuss prognostic factors informing treatment, the promising results of recent trials in new therapeutic approaches, and the implications of treatment resistance in therapeutic selection for MCL.
Target Audience
Hematology/oncology fellows, attending faculty, and other health care professionals involved in the treatment of patients with mantle cell lymphoma (MCL).
Learning Objectives
1.) Identify clinical and biological prognostic factors that can guide treatment decision making for older adults with MCL
2.) Evaluate emerging data on targeted therapeutic approaches for treatment-naive and relapsed/refractory MCL and their applicability to older adults
3.) Assess mechanisms of resistance to targeted therapies for MCL and their implications for treatment selection
HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...GL Anaacs
Contact us if you are interested:
Email / Skype : kefaya1771@gmail.com
Threema: PXHY5PDH
New BATCH Ku !!! MUCH IN DEMAND FAST SALE EVERY BATCH HAPPY GOOD EFFECT BIG BATCH !
Contact me on Threema or skype to start big business!!
Hot-sale products:
NEW HOT EUTYLONE WHITE CRYSTAL!!
5cl-adba precursor (semi finished )
5cl-adba raw materials
ADBB precursor (semi finished )
ADBB raw materials
APVP powder
5fadb/4f-adb
Jwh018 / Jwh210
Eutylone crystal
Protonitazene (hydrochloride) CAS: 119276-01-6
Flubrotizolam CAS: 57801-95-3
Metonitazene CAS: 14680-51-4
Payment terms: Western Union,MoneyGram,Bitcoin or USDT.
Deliver Time: Usually 7-15days
Shipping method: FedEx, TNT, DHL,UPS etc.Our deliveries are 100% safe, fast, reliable and discreet.
Samples will be sent for your evaluation!If you are interested in, please contact me, let's talk details.
We specializes in exporting high quality Research chemical, medical intermediate, Pharmaceutical chemicals and so on. Products are exported to USA, Canada, France, Korea, Japan,Russia, Southeast Asia and other countries.
Title: Sense of Smell
Presenter: Dr. Faiza, Assistant Professor of Physiology
Qualifications:
MBBS (Best Graduate, AIMC Lahore)
FCPS Physiology
ICMT, CHPE, DHPE (STMU)
MPH (GC University, Faisalabad)
MBA (Virtual University of Pakistan)
Learning Objectives:
Describe the primary categories of smells and the concept of odor blindness.
Explain the structure and location of the olfactory membrane and mucosa, including the types and roles of cells involved in olfaction.
Describe the pathway and mechanisms of olfactory signal transmission from the olfactory receptors to the brain.
Illustrate the biochemical cascade triggered by odorant binding to olfactory receptors, including the role of G-proteins and second messengers in generating an action potential.
Identify different types of olfactory disorders such as anosmia, hyposmia, hyperosmia, and dysosmia, including their potential causes.
Key Topics:
Olfactory Genes:
3% of the human genome accounts for olfactory genes.
400 genes for odorant receptors.
Olfactory Membrane:
Located in the superior part of the nasal cavity.
Medially: Folds downward along the superior septum.
Laterally: Folds over the superior turbinate and upper surface of the middle turbinate.
Total surface area: 5-10 square centimeters.
Olfactory Mucosa:
Olfactory Cells: Bipolar nerve cells derived from the CNS (100 million), with 4-25 olfactory cilia per cell.
Sustentacular Cells: Produce mucus and maintain ionic and molecular environment.
Basal Cells: Replace worn-out olfactory cells with an average lifespan of 1-2 months.
Bowman’s Gland: Secretes mucus.
Stimulation of Olfactory Cells:
Odorant dissolves in mucus and attaches to receptors on olfactory cilia.
Involves a cascade effect through G-proteins and second messengers, leading to depolarization and action potential generation in the olfactory nerve.
Quality of a Good Odorant:
Small (3-20 Carbon atoms), volatile, water-soluble, and lipid-soluble.
Facilitated by odorant-binding proteins in mucus.
Membrane Potential and Action Potential:
Resting membrane potential: -55mV.
Action potential frequency in the olfactory nerve increases with odorant strength.
Adaptation Towards the Sense of Smell:
Rapid adaptation within the first second, with further slow adaptation.
Psychological adaptation greater than receptor adaptation, involving feedback inhibition from the central nervous system.
Primary Sensations of Smell:
Camphoraceous, Musky, Floral, Pepperminty, Ethereal, Pungent, Putrid.
Odor Detection Threshold:
Examples: Hydrogen sulfide (0.0005 ppm), Methyl-mercaptan (0.002 ppm).
Some toxic substances are odorless at lethal concentrations.
Characteristics of Smell:
Odor blindness for single substances due to lack of appropriate receptor protein.
Behavioral and emotional influences of smell.
Transmission of Olfactory Signals:
From olfactory cells to glomeruli in the olfactory bulb, involving lateral inhibition.
Primitive, less old, and new olfactory systems with different path
Anti ulcer drugs and their Advance pharmacology ||
Anti-ulcer drugs are medications used to prevent and treat ulcers in the stomach and upper part of the small intestine (duodenal ulcers). These ulcers are often caused by an imbalance between stomach acid and the mucosal lining, which protects the stomach lining.
||Scope: Overview of various classes of anti-ulcer drugs, their mechanisms of action, indications, side effects, and clinical considerations.
Ethanol (CH3CH2OH), or beverage alcohol, is a two-carbon alcohol
that is rapidly distributed in the body and brain. Ethanol alters many
neurochemical systems and has rewarding and addictive properties. It
is the oldest recreational drug and likely contributes to more morbidity,
mortality, and public health costs than all illicit drugs combined. The
5th edition of the Diagnostic and Statistical Manual of Mental Disorders
(DSM-5) integrates alcohol abuse and alcohol dependence into a single
disorder called alcohol use disorder (AUD), with mild, moderate,
and severe subclassifications (American Psychiatric Association, 2013).
In the DSM-5, all types of substance abuse and dependence have been
combined into a single substance use disorder (SUD) on a continuum
from mild to severe. A diagnosis of AUD requires that at least two of
the 11 DSM-5 behaviors be present within a 12-month period (mild
AUD: 2–3 criteria; moderate AUD: 4–5 criteria; severe AUD: 6–11 criteria).
The four main behavioral effects of AUD are impaired control over
drinking, negative social consequences, risky use, and altered physiological
effects (tolerance, withdrawal). This chapter presents an overview
of the prevalence and harmful consequences of AUD in the U.S.,
the systemic nature of the disease, neurocircuitry and stages of AUD,
comorbidities, fetal alcohol spectrum disorders, genetic risk factors, and
pharmacotherapies for AUD.
ARTIFICIAL INTELLIGENCE IN HEALTHCARE.pdfAnujkumaranit
Artificial intelligence (AI) refers to the simulation of human intelligence processes by machines, especially computer systems. It encompasses tasks such as learning, reasoning, problem-solving, perception, and language understanding. AI technologies are revolutionizing various fields, from healthcare to finance, by enabling machines to perform tasks that typically require human intelligence.
These lecture slides, by Dr Sidra Arshad, offer a quick overview of physiological basis of a normal electrocardiogram.
Learning objectives:
1. Define an electrocardiogram (ECG) and electrocardiography
2. Describe how dipoles generated by the heart produce the waveforms of the ECG
3. Describe the components of a normal electrocardiogram of a typical bipolar leads (limb II)
4. Differentiate between intervals and segments
5. Enlist some common indications for obtaining an ECG
Study Resources:
1. Chapter 11, Guyton and Hall Textbook of Medical Physiology, 14th edition
2. Chapter 9, Human Physiology - From Cells to Systems, Lauralee Sherwood, 9th edition
3. Chapter 29, Ganong’s Review of Medical Physiology, 26th edition
4. Electrocardiogram, StatPearls - https://www.ncbi.nlm.nih.gov/books/NBK549803/
5. ECG in Medical Practice by ABM Abdullah, 4th edition
6. ECG Basics, http://www.nataliescasebook.com/tag/e-c-g-basics
These simplified slides by Dr. Sidra Arshad present an overview of the non-respiratory functions of the respiratory tract.
Learning objectives:
1. Enlist the non-respiratory functions of the respiratory tract
2. Briefly explain how these functions are carried out
3. Discuss the significance of dead space
4. Differentiate between minute ventilation and alveolar ventilation
5. Describe the cough and sneeze reflexes
Study Resources:
1. Chapter 39, Guyton and Hall Textbook of Medical Physiology, 14th edition
2. Chapter 34, Ganong’s Review of Medical Physiology, 26th edition
3. Chapter 17, Human Physiology by Lauralee Sherwood, 9th edition
4. Non-respiratory functions of the lungs https://academic.oup.com/bjaed/article/13/3/98/278874
Factory Supply Best Quality Pmk Oil CAS 28578–16–7 PMK Powder in Stockrebeccabio
Factory Supply Best Quality Pmk Oil CAS 28578–16–7 PMK Powder in Stock
Telegram: bmksupplier
signal: +85264872720
threema: TUD4A6YC
You can contact me on Telegram or Threema
Communicate promptly and reply
Free of customs clearance, Double Clearance 100% pass delivery to USA, Canada, Spain, Germany, Netherland, Poland, Italy, Sweden, UK, Czech Republic, Australia, Mexico, Russia, Ukraine, Kazakhstan.Door to door service
Hot Selling Organic intermediates
Prix Galien International 2024 Forum ProgramLevi Shapiro
June 20, 2024, Prix Galien International and Jerusalem Ethics Forum in ROME. Detailed agenda including panels:
- ADVANCES IN CARDIOLOGY: A NEW PARADIGM IS COMING
- WOMEN’S HEALTH: FERTILITY PRESERVATION
- WHAT’S NEW IN THE TREATMENT OF INFECTIOUS,
ONCOLOGICAL AND INFLAMMATORY SKIN DISEASES?
- ARTIFICIAL INTELLIGENCE AND ETHICS
- GENE THERAPY
- BEYOND BORDERS: GLOBAL INITIATIVES FOR DEMOCRATIZING LIFE SCIENCE TECHNOLOGIES AND PROMOTING ACCESS TO HEALTHCARE
- ETHICAL CHALLENGES IN LIFE SCIENCES
- Prix Galien International Awards Ceremony
5. Contrasts between 2 types of ARDS Kallet, R & Branson, R. Resp. Care Journal, Apr 2007, Vol 52 No 4 >10 usually present Lower inflec. Pt Severely Reduced Reduced Lung Compl. Response to PEEP Recruitment Potential Risk of overdistention Normal Reduced Chest Wall Compliance Pulmonary ARDS Extrapulmonary ARDS Mechanics
7. Contrasts between 2 types of ARDS Kallet, R & Branson, R. Resp. Care Journal, Apr 2007, Vol 52 No 4 >10 usually present Lower inflec. Pt Severely Reduced Reduced Lung Compl. Response to PEEP Recruitment Potential Low Risk of overdistention Normal Reduced Chest Wall Compliance Pulmonary ARDS Extrapulmonary ARDS Mechanics
9. Contrasts between 2 types of ARDS Kallet, R & Branson, R. Resp. Care Journal, Apr 2007, Vol 52 No 4 >10 usually present Lower inflec. Pt Severely Reduced Reduced Lung Compl. Excellent (10-20 cm) Response to PEEP High Recruitment Potential Low Risk of overdistention Normal Reduced Chest Wall Compliance Pulmonary ARDS Extrapulmonary ARDS Mechanics
11. Contrasts between 2 types of ARDS Kallet, R & Branson, R. Resp. Care Journal, Apr 2007, Vol 52 No 4 <10 cm often absent >10 usually present Lower inflec. Pt Severely Reduced Reduced Lung Compl. Excellent (10-20cm) Response to PEEP High Recruitment Potential Low Risk of overdistention Normal Reduced Chest Wall Compliance Pulmonary ARDS Extrapulmonary ARDS Mechanics
13. Contrasts between 2 types of ARDS Kallet, R & Branson, R. Resp. Care Journal, Apr 2007, Vol 52 No 4 <10 cm often absent >10 usually present Lower inflec. Pt Severely Reduced Reduced Lung Compl. Excellent (10-20cm) Response to PEEP High Recruitment Potential High Low Risk of overdistention Normal Reduced Chest Wall Compliance Pulmonary ARDS Extrapulmonary ARDS Mechanics
70. Contrasts between 2 types of ARDS Kallet, R & Branson, R. Resp. Care Journal, Apr 2007, Vol 52 No 4 <10 cm often absent >10 usually present Lower inflec. Pt Severely Reduced Reduced Lung Compl. Excellent (10-20cm) Response to PEEP Low High Recruitment Potential High Low Risk of overdistention Normal Reduced Chest Wall Compliance Pulmonary ARDS Extrapulmonary ARDS Mechanics
72. Contrasts between 2 types of ARDS Kallet, R & Branson, R. Resp. Care Journal, Apr 2007, Vol 52 No 4 <10 cm often absent >10 usually present Lower inflec. Pt Severely Reduced Reduced Lung Compl. Good (8-12cm) Excellent (10-20cm) Response to PEEP Low High Recruitment Potential High Low Risk of overdistention Normal Reduced Chest Wall Compliance Pulmonary ARDS Extrapulmonary ARDS Mechanics
75. Tschumperlin, D et al. Am J Respir Crit Care Med, Vol 162. pp 357-362, 2000
76. Tschumperlin, D et al. Am J Respir Crit Care Med, Vol 162. pp 357-362, 2000 Both static and single deformations were significantly less injurious than cyclic deformations at each deformation level
77. Tschumperlin, D et al. Am J Respir Crit Care Med, Vol 162. pp 357-362, 2000 Reducing the amplitude reduced cell death Cell Death dependent on frequency
112. I-times in Pressure Modes for Full Flow deceleration improve gas distribution and minimize PC level F T P T MAP MAP Vt Vt
113. I-times in Pressure Modes for Full Flow deceleration improve gas distribution and minimize PC level F T P T MAP Vt Vt
114. I-times in Pressure Modes for Full Flow deceleration improve gas distribution and minimize PC level F T P T MAP Vt Min.Insp. Pressure Adjustments Needed Vt Vt
115.
116. Normal Ventilation with Normal MAP P Time PEEP PEEP Plat Peak Insp Mean Insp Pressure Mean Exp Pressure + = MAP 5 20 15
117. Increase in Insp. Pressure What will happen to MAP? P Time PEEP PEEP Plat Peak Insp Mean Insp Pressure Mean Exp Pressure + = MAP 5 20 15 25
118. Increase in Insp. Pressure What will happen to Plat ? P Time PEEP PEEP Plat Peak Insp Mean Insp Pressure Mean Exp Pressure + = MAP 5 20 15 25
119. Increase in PEEP, What will happen to MAP & Plat? P Time PEEP PEEP Plat Peak Insp Mean Insp Pressure Mean Exp Pressure + = MAP 5 20 15 10
120. APRV (Basically inverse Ratio with Spont. Breathing during insp. Phase.) Can Increase MAP and keep safe Plat. & spont. Breath. P Time PEEP PEEP Plat Peak Insp Mean Insp Pressure Mean Exp Pressure + = MAP 5 20 15 = If Flow is Fully dec. Spontaneous Breaths